| |
| |
|
| Insider
Information: |
Ciechanover Isaac E. |
| Relationship: |
Chief Executive Office... |
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
332,243 |
|
|
Indirect Shares
|
290,687 |
|
|
| Direct
Value |
$181,338 |
|
|
|
Indirect Value
|
$158,657 |
|
|
| Total
Shares |
622,930 |
|
|
| Total
Value |
$339,995 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Atara Biotherapeutics, Inc. |
ATRA |
Chief Executive Office... |
2019-05-30 |
332,243 |
2019-05-30 |
290,687 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
209 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 9
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
38,000 |
38,000 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-04-22 |
4 |
AS |
$60.01 |
$156,026 |
I/I |
(2,600) |
394,900 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-04-23 |
4 |
AS |
$62.70 |
$163,020 |
I/I |
(2,600) |
392,300 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-05-15 |
4 |
GA |
$0.00 |
$0 |
I/I |
19,082 |
411,382 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-05-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
19,082 |
35,625 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-05-15 |
4 |
D |
$37.30 |
$552,077 |
D/D |
(14,801) |
54,707 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,508 |
69,508 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-05-21 |
4 |
AS |
$37.06 |
$74,966 |
I/I |
(2,000) |
409,382 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-05-22 |
4 |
AS |
$37.40 |
$75,256 |
I/I |
(2,000) |
407,382 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-06-04 |
4 |
AS |
$41.22 |
$159,911 |
I/I |
(3,800) |
403,582 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-06-05 |
4 |
AS |
$43.74 |
$114,685 |
I/I |
(2,600) |
400,982 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-06-17 |
4 |
AS |
$54.86 |
$143,080 |
I/I |
(2,600) |
398,382 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-06-18 |
4 |
AS |
$52.62 |
$141,465 |
I/I |
(2,600) |
395,782 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-06-30 |
4 |
AS |
$51.65 |
$137,616 |
I/I |
(2,600) |
393,182 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-07-01 |
4 |
AS |
$45.25 |
$124,544 |
I/I |
(2,600) |
390,582 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-07-16 |
4 |
AS |
$60.90 |
$159,292 |
I/I |
(2,600) |
387,982 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-07-17 |
4 |
AS |
$59.90 |
$156,388 |
I/I |
(2,600) |
385,382 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-07-30 |
4 |
AS |
$56.05 |
$145,946 |
I/I |
(2,600) |
382,782 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-07-31 |
4 |
AS |
$55.41 |
$146,214 |
I/I |
(2,600) |
380,182 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-08-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,907 |
41,532 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-08-27 |
4 |
AS |
$38.15 |
$101,209 |
I/I |
(2,600) |
377,582 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-08-28 |
4 |
AS |
$39.20 |
$102,877 |
I/I |
(2,600) |
374,982 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-09-10 |
4 |
AS |
$44.67 |
$119,324 |
I/I |
(2,600) |
410,211 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-09-11 |
4 |
AS |
$45.42 |
$115,947 |
I/I |
(2,500) |
407,711 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-09-11 |
4 |
AS |
$47.74 |
$4,774 |
D/D |
(100) |
407,611 |
0 |
- |
|
209 Records found
|
|
Page 1 of 9 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
